Medtronic (NYSE:MDT) said a clinical study for its Affera Mapping and Ablation System with Sphere-9 Catheter for the treatment of persistent atrial fibrillation has met its endpoints for safety and ...

Sphere-9 demonstrated 73.8% freedom from AFib vs. only 65.8% observed in the control arm. AFib is one of the most common and undertreated heart rhythm disorders, affecting more than 60 million people ...

BERLIN, Germany—A novel conformable pulsed-field ablation (PFA) catheter that contains both mapping and ablation capabilities can efficiently and safely isolate the pulmonary veins in patients with ...